Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 289

1.

Very late scaffold thrombosis after everolimus-eluting bioresorbable scaffold implantation in patients with unremarkable interim surveillance angiography.

Hoppmann P, Rai H, Colleran R, Kufner S, Wiebe J, Cassese S, Joner M, Laugwitz KL, Kastrati A, Byrne RA.

Cardiovasc Revasc Med. 2019 May 30. pii: S1553-8389(19)30322-7. doi: 10.1016/j.carrev.2019.05.023. [Epub ahead of print]

PMID:
31231028
2.

Optical coherence tomography tissue coverage and characterization with grey-scale signal intensity analysis after bifurcation stenting with a new generation bioabsorbable polymer drug-eluting stent.

Rai H, Hussein H, Colleran R, Xhepa E, Wiebe J, Pinieck S, Cassese S, Joner M, Kastrati A, Byrne RA, Foley DP.

Cardiovasc Revasc Med. 2019 May 8. pii: S1553-8389(19)30302-1. doi: 10.1016/j.carrev.2019.05.004. [Epub ahead of print]

PMID:
31155492
3.

Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk.

Urban P, Mehran R, Colleran R, Angiolillo DJ, Byrne RA, Capodanno D, Cuisset T, Cutlip D, Eerdmans P, Eikelboom J, Farb A, Gibson CM, Gregson J, Haude M, James SK, Kim HS, Kimura T, Konishi A, Laschinger J, Leon MB, Magee PFA, Mitsutake Y, Mylotte D, Pocock S, Price MJ, Rao SV, Spitzer E, Stockbridge N, Valgimigli M, Varenne O, Windhoevel U, Yeh RW, Krucoff MW, Morice MC.

Eur Heart J. 2019 May 22. pii: ehz372. doi: 10.1093/eurheartj/ehz372. [Epub ahead of print]

PMID:
31116395
4.

Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention: A Consensus Document From the Academic Research Consortium for High Bleeding Risk.

Urban P, Mehran R, Colleran R, Angiolillo DJ, Byrne RA, Capodanno D, Cuisset T, Cutlip D, Eerdmans P, Eikelboom J, Farb A, Gibson CM, Gregson J, Haude M, James SK, Kim HS, Kimura T, Konishi A, Laschinger J, Leon MB, Magee PFA, Mitsutake Y, Mylotte D, Pocock S, Price MJ, Rao SV, Spitzer E, Stockbridge N, Valgimigli M, Varenne O, Windhoevel U, Yeh RW, Krucoff MW, Morice MC.

Circulation. 2019 May 22. doi: 10.1161/CIRCULATIONAHA.119.040167. [Epub ahead of print]

PMID:
31116032
5.

Clinical use of intracoronary imaging. Part 2: acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions.

Johnson TW, Räber L, di Mario C, Bourantas C, Jia H, Mattesini A, Gonzalo N, de la Torre Hernandez JM, Prati F, Koskinas K, Joner M, Radu MD, Erlinge D, Regar E, Kunadian V, Maehara A, Byrne RA, Capodanno D, Akasaka T, Wijns W, Mintz GS, Guagliumi G.

Eur Heart J. 2019 May 21. pii: ehz332. doi: 10.1093/eurheartj/ehz332. [Epub ahead of print]

PMID:
31112213
6.

EuroIntervention and EuroPCR 2019 - together embodying the spirit of interventional cardiology.

Serruys PW, Mylotte D, Capodanno D, Søndergaard L, Byrne RA.

EuroIntervention. 2019 May 20;15(1):13-15. doi: 10.4244/EIJV15I1A1. No abstract available.

7.

Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials.

Piccolo R, Bonaa KH, Efthimiou O, Varenne O, Baldo A, Urban P, Kaiser C, Remkes W, Räber L, de Belder A, van 't Hof AWJ, Stankovic G, Lemos PA, Wilsgaard T, Reifart J, Rodriguez AE, Ribeiro EE, Serruys PWJC, Abizaid A, Sabaté M, Byrne RA, de la Torre Hernandez JM, Wijns W, Jüni P, Windecker S, Valgimigli M; Coronary Stent Trialists' Collaboration.

Lancet. 2019 Jun 22;393(10190):2503-2510. doi: 10.1016/S0140-6736(19)30474-X. Epub 2019 May 2. Erratum in: Lancet. 2019 Jun 22;393(10190):2492.

PMID:
31056295
8.

Patient focus in interventional cardiology: proceedings of the 2018 summit of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) - Nice, France, 20-21 June 2018.

Barbato E, Mauri J, Byrne RA, Roffi M, Fitzsimons D, Toth G, Capodanno D, Mehilli J, Petronio AS, Chieffo A, Vardas P, Naber CK, Dudek D, Haude M, Baumbach A.

EuroIntervention. 2019 Apr 20;14(17):1720-1723. doi: 10.4244/EIJV14I17A297. No abstract available.

9.

Omission of aspirin after ACS or stenting in patients with oral anticoagulation - why have the goalposts moved?

Byrne RA, Colleran R, Kastrati A.

EuroIntervention. 2019 Apr 5;14(18):e1793-e1795. doi: 10.4244/EIJV14I18A312. No abstract available.

10.

Do outcomes following intervention for drug-eluting stent restenosis depend on whether the restenosed stent was polymer-free or polymer-coated?

Harada Y, Schneider S, Colleran R, Rai H, Bohner J, Kuna C, Kufner S, Giacoppo D, Schüpke S, Joner M, Ibrahim T, Laugwitz KL, Kastrati A, Byrne RA.

Rev Esp Cardiol (Engl Ed). 2019 Mar 13. pii: S1885-5857(19)30029-5. doi: 10.1016/j.rec.2019.01.005. [Epub ahead of print] English, Spanish.

PMID:
30878234
11.

Qualitative and quantitative neointimal characterization by optical coherence tomography in patients presenting with in-stent restenosis.

Xhepa E, Byrne RA, Rivero F, Rroku A, Cuesta J, Ndrepepa G, Kufner S, Valiente TB, Cassese S, Garcia-Guimaraes M, Lahmann AL, Rai H, Schunkert H, Joner M, Pérez-Vizcayno MJ, Gonzalo N, Alfonso F, Kastrati A.

Clin Res Cardiol. 2019 Feb 19. doi: 10.1007/s00392-019-01439-5. [Epub ahead of print]

PMID:
30783752
12.

Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary intervention.

Kessler T, Wolf B, Eriksson N, Kofink D, Mahmoodi BK, Rai H, Tragante V, Åkerblom A, Becker RC, Bernlochner I, Bopp R, James S, Katus HA, Mayer K, Munz M, Nordio F, O'Donoghue ML, Sager HB, Sibbing D, Solakov L, Storey RF, Wobst J, Asselbergs FW, Byrne RA, Erdmann J, Koenig W, Laugwitz KL, Ten Berg JM, Wallentin L, Kastrati A, Schunkert H.

Cardiovasc Res. 2019 Feb 14. pii: cvz015. doi: 10.1093/cvr/cvz015. [Epub ahead of print]

PMID:
30768153
13.

Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents. A pooled analysis of individual patient data from 2 randomized trials.

Cassese S, Katagiri Y, Byrne RA, Brugaletta S, Alfonso F, Räber L, Maeng M, Iñiguez A, Kretov E, Onuma Y, Joner M, Sabaté M, Laugwitz KL, Windecker S, Kastrati A, Serruys PW.

EuroIntervention. 2019 Feb 5. pii: EIJ-D-18-01080. doi: 10.4244/EIJ-D-18-01080. [Epub ahead of print]

14.

Progress in the monitoring of direct oral anticoagulant therapy.

Patel JP, Byrne RA, Patel RK, Arya R.

Br J Haematol. 2019 Mar;184(6):912-924. doi: 10.1111/bjh.15756. Epub 2019 Jan 29. Review.

PMID:
30697708
15.

FOXO3 is involved in the tumor necrosis factor-driven inflammatory response in fibroblast-like synoviocytes.

Brandstetter B, Dalwigk K, Platzer A, Niederreiter B, Kartnig F, Fischer A, Vladimer GI, Byrne RA, Sevelda F, Holinka J, Pap T, Steiner G, Superti-Furga G, Smolen JS, Kiener HP, Karonitsch T.

Lab Invest. 2019 May;99(5):648-658. doi: 10.1038/s41374-018-0184-7. Epub 2019 Jan 24.

PMID:
30679758
16.

2018 ESC/EACTS Guidelines on myocardial revascularization.

Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Jüni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferović PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO.

EuroIntervention. 2019 Feb 20;14(14):1435-1534. doi: 10.4244/EIJY19M01_01. No abstract available.

17.

Peripheral nerve transfers change target muscle structure and function.

Bergmeister KD, Aman M, Muceli S, Vujaklija I, Manzano-Szalai K, Unger E, Byrne RA, Scheinecker C, Riedl O, Salminger S, Frommlet F, Borschel GH, Farina D, Aszmann OC.

Sci Adv. 2019 Jan 2;5(1):eaau2956. doi: 10.1126/sciadv.aau2956. eCollection 2019 Jan.

18.

Ten-Year Clinical Outcomes From a Trial of Three Limus-Eluting Stents With Different Polymer Coatings in Patients With Coronary Artery Disease.

Kufner S, Joner M, Thannheimer A, Hoppmann P, Ibrahim T, Mayer K, Cassese S, Laugwitz KL, Schunkert H, Kastrati A, Byrne RA; ISAR-TEST 4 (Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents) Investigators.

Circulation. 2019 Jan 15;139(3):325-333. doi: 10.1161/CIRCULATIONAHA.118.038065.

PMID:
30586724
19.

[2018 ESC/EACTS Guidelines on myocardial revascularization].

Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Juni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferović PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO.

Kardiol Pol. 2018;76(12):1585-1664. doi: 10.5603/KP.2018.0228. Polish. No abstract available.

20.

Prognostic Impact of Periprocedural Myocardial Infarction in Patients Undergoing Elective Percutaneous Coronary Interventions.

Koskinas KC, Ndrepepa G, Räber L, Karagiannis A, Kufner S, Zanchin T, Hieber J, Hunziker L, Mayer K, Byrne RA, Heg D, Windecker S, Kastrati A.

Circ Cardiovasc Interv. 2018 Dec;11(12):e006752. doi: 10.1161/CIRCINTERVENTIONS.118.006752.

PMID:
30545257
21.

Prospective, randomized trial of bioresorbable scaffolds vs. everolimus-eluting stents in patients undergoing coronary stenting for myocardial infarction: the Intracoronary Scaffold Assessment a Randomized evaluation of Absorb in Myocardial Infarction (ISAR-Absorb MI) trial.

Byrne RA, Alfonso F, Schneider S, Maeng M, Wiebe J, Kretov E, Bradaric C, Rai H, Cuesta J, Rivero F, Hoppmann P, Schlichtenmaier J, Christiansen EH, Cassese S, Joner M, Schunkert H, Laugwitz KL, Kastrati A.

Eur Heart J. 2019 Jan 7;40(2):167-176. doi: 10.1093/eurheartj/ehy710.

PMID:
30520980
22.

Outcome after new generation single-layer polytetrafluoroethylene-covered stent implantation for the treatment of coronary artery perforation.

Kufner S, Schacher N, Ferenc M, Schlundt C, Hoppmann P, Abdel-Wahab M, Mayer K, Fusaro M, Byrne RA, Kastrati A.

Catheter Cardiovasc Interv. 2019 Apr 1;93(5):912-920. doi: 10.1002/ccd.27979. Epub 2018 Nov 23.

PMID:
30467994
23.

The ESC Congress 2018 and the legacy of Eugene Braunwald.

Byrne RA.

EuroIntervention. 2018 Nov 20;14(10):1067-1068. doi: 10.4244/EIJV14I10A190. No abstract available.

24.

Comparison of Vascular Closure Devices Versus Manual Compression After Femoral Artery Puncture in Women.

Gewalt SM, Helde SM, Ibrahim T, Mayer K, Schmidt R, Bott-Flügel L, Hoppe K, Ott I, Hieber J, Morath T, Byrne RA, Kufner S, Cassese S, Hoppmann P, Fusaro M, Schunkert H, Laugwitz KL, Kastrati A, Schüpke S; Instrumental Sealing of Arterial Puncture Site—CLOSURE Device Versus Manual Compression (ISAR-CLOSURE) Trial Investigators.

Circ Cardiovasc Interv. 2018 Aug;11(8):e006074. doi: 10.1161/CIRCINTERVENTIONS.117.006074.

PMID:
30354782
25.

High-Speed Rotational Atherectomy Versus Modified Balloons Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Lesions.

Abdel-Wahab M, Toelg R, Byrne RA, Geist V, El-Mawardy M, Allali A, Rheude T, Robinson DR, Abdelghani M, Sulimov DS, Kastrati A, Richardt G.

Circ Cardiovasc Interv. 2018 Oct;11(10):e007415. doi: 10.1161/CIRCINTERVENTIONS.118.007415. Erratum in: Circ Cardiovasc Interv. 2018 Oct;11(10):e000040.

PMID:
30354632
26.

Strengths and Limitations of Real World Data in Patients Treated With Coronary Stents.

Byrne RA, Colleran R, Kastrati A.

Circ Cardiovasc Interv. 2018 Sep;11(9):e007239. doi: 10.1161/CIRCINTERVENTIONS.118.007239. No abstract available.

PMID:
30354605
27.

Early maternal feeding practices: Associations with overweight later in childhood.

Haszard JJ, Russell CG, Byrne RA, Taylor RW, Campbell KJ.

Appetite. 2019 Jan 1;132:91-96. doi: 10.1016/j.appet.2018.10.008. Epub 2018 Oct 9.

PMID:
30308224
28.

Endovascular stenting in femoropopliteal arteries.

Cassese S, Byrne RA.

Lancet. 2018 Oct 27;392(10157):1491-1493. doi: 10.1016/S0140-6736(18)32339-0. Epub 2018 Sep 24. No abstract available.

PMID:
30262333
29.

2018 ESC/EACTS Guidelines on myocardial revascularization.

Sousa-Uva M, Neumann FJ, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Jüni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO; ESC Scientific Document Group.

Eur J Cardiothorac Surg. 2019 Jan 1;55(1):4-90. doi: 10.1093/ejcts/ezy289. No abstract available.

PMID:
30165632
30.

2018 ESC/EACTS Guidelines on myocardial revascularization.

Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Jüni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO; ESC Scientific Document Group .

Eur Heart J. 2019 Jan 7;40(2):87-165. doi: 10.1093/eurheartj/ehy394. No abstract available.

PMID:
30165437
31.

The use and impact of clinical practice guidelines in interventional cardiology.

Byrne RA.

EuroIntervention. 2018 Aug 20;14(6):607-608. doi: 10.4244/EIJV14I6A106. No abstract available.

32.

Sex and Long-Term Outcomes After Implantation of Absorb Bioresorbable Vascular Scaffold for Treatment of Coronary Artery Disease.

Baquet M, Hoppmann P, Grundmann D, Schmidt W, Kufner S, Theiss HD, Brunner S, Wiebe J, Eickhoff M, Jochheim D, Byrne RA, Laugwitz KL, Schunkert H, Massberg S, Kastrati A, Mehilli J.

EuroIntervention. 2018 Aug 14. pii: EIJ-D-18-00603. doi: 10.4244/EIJ-D-18-00603. [Epub ahead of print]

33.

Neoatherosclerosis in Patients With Coronary Stent Thrombosis: Findings From Optical Coherence Tomography Imaging (A Report of the PRESTIGE Consortium).

Joner M, Koppara T, Byrne RA, Castellanos MI, Lewerich J, Novotny J, Guagliumi G, Xhepa E, Adriaenssens T, Godschalk TC, Malik N, Alfonso F, Tada T, Neumann FJ, Desmet W, Ten Berg JM, Gershlick AH, Feldman LJ, Massberg S, Kastrati A; Prevention of PRESTIGE Investigators.

JACC Cardiovasc Interv. 2018 Jul 23;11(14):1340-1350. doi: 10.1016/j.jcin.2018.02.029.

PMID:
30025727
34.

Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions.

Räber L, Mintz GS, Koskinas KC, Johnson TW, Holm NR, Onuma Y, Radu MD, Joner M, Yu B, Jia H, Meneveau N, de la Torre Hernandez JM, Escaned J, Hill J, Prati F, Colombo A, Di Mario C, Regar E, Capodanno D, Wijns W, Byrne RA, Guagliumi G.

EuroIntervention. 2018 Aug 20;14(6):656-677. doi: 10.4244/EIJY18M06_01.

35.

The discovery of X-rays, the fate of atomic bomb survivors, and the impact on modern interventional cardiology.

Byrne RA.

EuroIntervention. 2018 Jun 20;14(2):129-131. doi: 10.4244/EIJV14I2A18. No abstract available.

36.

Long-term effectiveness and safety of transcatheter closure of patent foramen ovale compared with antithrombotic therapy alone: a meta-analysis of six randomised clinical trials and 3,560 patients with reconstructed time-to-event data.

Giacoppo D, Caronna N, Frangieh AH, Michel J, Andò G, Tarantini G, Kasel AM, Capodanno D, Byrne RA.

EuroIntervention. 2018 Oct 20;14(8):857-867. doi: 10.4244/EIJ-D-18-00341.

37.

Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions.

Räber L, Mintz GS, Koskinas KC, Johnson TW, Holm NR, Onuma Y, Radu MD, Joner M, Yu B, Jia H, Meneveau N, de la Torre Hernandez JM, Escaned J, Hill J, Prati F, Colombo A, di Mario C, Regar E, Capodanno D, Wijns W, Byrne RA, Guagliumi G; ESC Scientific Document Group .

Eur Heart J. 2018 Sep 14;39(35):3281-3300. doi: 10.1093/eurheartj/ehy285.

PMID:
29790954
38.

Percutaneous coronary and structural interventions in women: a position statement from the EAPCI Women Committee.

Chieffo A, Buchanan GL, Mehilli J, Capodanno D, Kunadian V, Petronio AS, Mikhail GW, Capranzano P, Gonzal N, Karam N, Manzo-Silberman S, Schüpke S, Byrne RA, Capretti G, Appelman Y, Morice MC, Presbitero P, Radu M, Mauri J.

EuroIntervention. 2018 Dec 7;14(11):e1227-e1235. doi: 10.4244/EIJ-D-18-00225.

39.

Evaluating the importance of sham-controlled trials in the investigation of medical devices in interventional cardiology.

Byrne RA, Capodanno D, Mahfoud F, Fajadet J, Windecker S, Jüni P, Baumbach A, Wijns W, Haude M.

EuroIntervention. 2018 Aug 20;14(6):708-715. doi: 10.4244/EIJ-D-18-00481.

40.

Efficacy Over Time With Drug-Eluting Stents in Saphenous Vein Graft Lesions.

Colleran R, Kufner S, Mehilli J, Rosenbeiger C, Schüpke S, Hoppmann P, Joner M, Mankerious N, Fusaro M, Cassese S, Abdel-Wahab M, Neumann FJ, Richardt G, Ibrahim T, Schunkert H, Laugwitz KL, Kastrati A, Byrne RA; ISAR-CABG Investigators.

J Am Coll Cardiol. 2018 May 8;71(18):1973-1982. doi: 10.1016/j.jacc.2018.03.456.

41.

Markers of Reperfusion and Long-Term (8-Year) Prognosis after Primary Percutaneous Coronary Intervention.

Ndrepepa G, Byrne RA, Cassese S, Fusaro M, Colleran R, Hieber J, Laugwitz KL, Schunkert H, Kastrati A.

Am J Cardiol. 2018 Jul 1;122(1):39-46. doi: 10.1016/j.amjcard.2018.03.353. Epub 2018 Apr 9.

PMID:
29706204
42.

What interventionalists can learn from the aviation industry.

Byrne RA.

EuroIntervention. 2018 Apr 20;13(17):1977-1979. doi: 10.4244/EIJV13I17A321. No abstract available.

43.

Challenges in Patients with Diabetes: Improving Clinical Outcomes After Percutaneous Coronary Intervention Through EVOlving Stent Technology.

Byrne RA, Banai S, Colleran R, Colombo A.

Interv Cardiol. 2018 Jan;13(1):40-44. doi: 10.15420/icr.2017:27:1.

44.

PCI in Patients with Diabetes: Role of the Cre8 Drug-eluting Stent.

Byrne RA, Eeckhout E, Sardella G, Stella P, Verheye S.

Interv Cardiol. 2017 May;12(1):13-17. doi: 10.15420/icr.2016:28:2.

45.

Randomised comparison of vascular response to biodegradable polymer sirolimus eluting and permanent polymer everolimus eluting stents: An optical coherence tomography study.

Koppara T, Tada T, Xhepa E, Kufner S, Byrne RA, Ibrahim T, Laugwitz KL, Kastrati A, Joner M.

Int J Cardiol. 2018 May 1;258:42-49. doi: 10.1016/j.ijcard.2018.01.011.

PMID:
29544956
46.

Current Use of Intracoronary Imaging in Interventional Practice - Results of a European Association of Percutaneous Cardiovascular Interventions (EAPCI) and Japanese Association of Cardiovascular Interventions and Therapeutics (CVIT) Clinical Practice Survey.

Koskinas KC, Nakamura M, Räber L, Colleran R, Kadota K, Capodanno D, Wijns W, Akasaka T, Valgimigli M, Guagliumi G, Windecker S, Byrne RA.

Circ J. 2018 Apr 25;82(5):1360-1368. doi: 10.1253/circj.CJ-17-1144. Epub 2018 Mar 15.

47.

Current use of intracoronary imaging in interventional practice - Results of a European Association of Percutaneous Cardiovascular Interventions (EAPCI) and Japanese Association of Cardiovascular Interventions and Therapeutics (CVIT) Clinical Practice Survey.

Koskinas KC, Nakamura M, Räber L, Colleran R, Kadota K, Capodanno D, Wijns W, Akasaka T, Valgimigli M, Guagliumi G, Windecker S, Byrne RA.

EuroIntervention. 2018 Jul 20;14(4):e475-e484. doi: 10.4244/EIJY18M03_01.

48.

Outcomes of patients treated with ultrathin-strut biodegradable polymer sirolimus-eluting stents versus fluoropolymer-based everolimus-eluting stents: a meta-analysis of randomised trials.

Cassese S, Ndrepepa G, Byrne RA, Kufner S, Lahmann AL, Mankerious N, Xhepa E, Laugwitz KL, Schunkert H, Fusaro M, Kastrati A, Joner M.

EuroIntervention. 2018 Jun 20;14(2):224-231. doi: 10.4244/EIJ-D-18-00024.

49.

Evidence-based medicine, transparency and reproducibility in research, and challenges for peer review.

Byrne RA.

EuroIntervention. 2018 Feb 20;13(14):1615-1617. doi: 10.4244/EIJV13I14A259. No abstract available.

50.

Vascular response to percutaneous coronary intervention with biodegradable-polymer vs. new-generation durable-polymer drug-eluting stents: a meta-analysis of optical coherence tomography imaging trials.

Cassese S, Xhepa E, Ndrepepa G, Kufner S, Colleran R, Giacoppo D, Koppara T, Mankerious N, Byrne RA, Laugwitz KL, Schunkert H, Fusaro M, Kastrati A, Joner M.

Eur Heart J Cardiovasc Imaging. 2018 Nov 1;19(11):1294-1301. doi: 10.1093/ehjci/jex334. Review.

PMID:
29300853

Supplemental Content

Loading ...
Support Center